Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 2/20 | 0.36 |
| ▸ | TDP2 | O95551 | 4/20 | 0.34 |
| ▸ | AR | P10275 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | BRD2 | P25440 | 1/20 | 0.32 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.32 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.32 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17169539 | 0.85 | HTR7 (0.40) | HTR7BRD4ARALDH1A1CASP3 | |
| SCHEMBL24714559 | 0.84 | HTR7 (0.41) | HTR7ARALDH1A1CASP3EGLN2 | |
| SCHEMBL17169606 | 0.84 | HTR7 (0.41) | HTR7ARALDH1A1CASP3EGLN2 | |
| SCHEMBL18088253 | 0.82 | BRD4 (0.36) | BRD4TDP2ARALDH1A1CYP2A6 | |
| SCHEMBL17169534 | 0.81 | HTR7 (0.39) | HTR7BRD4ARALDH1A1CASP3 | |
| SCHEMBL17169535 | 0.81 | HTR7 (0.37) | HTR7BRD4ARALDH1A1EGLN2 | |
| SCHEMBL17169578 | 0.80 | HTR7 (0.36) | HTR7ALDH1A1EGLN2 | |
| SCHEMBL17169538 | 0.78 | FADS1 (0.40) | TDP2ALDH1A1TSHR | |
| SCHEMBL17169533 | 0.78 | HTR7 (0.39) | HTR7ARALDH1A1MEN1 | |
| SCHEMBL20881602 | 0.78 | HTT (0.38) | HTR7ALDH1A1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9911928-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-06 | — | — | US | disclosed |
| US-9905785-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-02-27 | — | — | US | disclosed |
| US-20160276603-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2016-09-22 | — | — | US | disclosed |
| US-20150295189-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160276603-A1 | Organic Electroluminescent Materials and Devices | EML4, BICRA, TBCB | HTR7 1804/4885BRD4 9/4885TDP2 3418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.